FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically dermatology, and may be used for treating the patients with psoriatic erythroderma. For this purpose, detoxification hormone therapy combined with external ointment therapy is preceded by prescribing Galavit in a therapeutic dose of 100 mg intramuscularly every day within the course of 10 procedures.
EFFECT: method provides higher clinical effectiveness ensured by a shorter length of therapy, no side effects and prolonged remission.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
METHOD OF PSORIASIS TREATMENT | 2007 |
|
RU2361605C2 |
METHOD OF TREATING PSORIASIS | 2009 |
|
RU2394575C1 |
METHOD OF TREATING GUTTATE PSORIASIS | 2011 |
|
RU2483762C2 |
METHOD OF TREATING PSORIASIS VULGARIS | 2011 |
|
RU2472541C1 |
METHOD OF EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2011 |
|
RU2462232C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716617C1 |
METHOD FOR EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2021 |
|
RU2773804C1 |
METHOD OF PSORIASIS VULGARIS TREATMENT | 2007 |
|
RU2349338C1 |
METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
Authors
Dates
2013-10-27—Published
2011-07-04—Filed